# A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo

> **NCT02644135** · NA · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Halo Oral Spray
- **DRUG:** Halo Placebo

## Key facts

- **NCT ID:** NCT02644135
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644135, "A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02644135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*